Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IT stocks lead among gainers
Wed, 17 Sep 11:30 am

After opening firm, the benchmark Indian indices have continued to trade strong during the morning trading session. Majority of sectoral indices are trading in green with software and realty stocks being the leading gainers in the pack.

The BSE-Sensex is trading up 134 points. The NSE-Nifty is trading up 42 points. The BSE Mid Cap index is trading down 0.10% while the BSE Small Cap index is trading up 0.39%. The rupee is trading at 61.10 to the US dollar.

Most software stocks are trading higher today. Infosys and Wipro are leading the gainers. As per a leading business daily, India's second largest software firm Infosys, has begun working with top Japanese retailer Muji, to develop an interactive software platform for its 2 m customers. Infosys will deploy its proprietary platform InteractEdge, to help the retailer realise real-time insights into consumer behavior. Muji has nearly 600 retail stores in Japan and is looking to enhance its online presence. InteractEdge will help the firm generate higher sales through personalised product recommendations by understanding its customer's preferences better. The financial details of this transaction were not disclosed. Japan is currently not a big market for Infosys but the IT firm is looking to expand its presence in the country. Infosys is currently trading up 1.6%.

Majority of Indian pharma stocks are trading firm with Dishman pharma and Biocon Ltd being among the leading gainers in the pack. As per the financial daily, multinational American drug maker Gilead has entered into alliance with pharma companies to sell hepatitis generics in 90 countries. The company has signed deal with Zydus Cadila, Cipla, Strides Acrolab, Hetero, Mylan. Reportedly, Since Gilead has applied for a patent on these drugs in many countries, including India. The deal is seen as its strategic move to leverage the drugs' potential, as well as save its patent protection, which is under attack in many countries. Gilead has given rights to these companies to sell its new hepatitis C medicines sofosbuvir and ledipasvir at lower prices. Cipla has also been given exclusive API supply rights. The domestic companies are expected to benefit from this deal.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "IT stocks lead among gainers". Click here!

  

Related Views on News

INFOSYS Announces Quarterly Results (3QFY21); Net Profit Up 16.8% (Quarterly Result Update)

Jan 14, 2021 | Updated on Jan 14, 2021

For the quarter ended December 2020, INFOSYS has posted a net profit of Rs 52 bn (up 16.8% YoY). Sales on the other hand came in at Rs 259 bn (up 12.3% YoY). Read on for a complete analysis of INFOSYS's quarterly results.

INFOSYS Announces Quarterly Results (2QFY21); Net Profit Up 20.3% (Quarterly Result Update)

Oct 15, 2020 | Updated on Oct 15, 2020

For the quarter ended September 2020, INFOSYS has posted a net profit of Rs 49 bn (up 20.3% YoY). Sales on the other hand came in at Rs 246 bn (up 8.6% YoY). Read on for a complete analysis of INFOSYS's quarterly results.

INFOSYS 2019-20 Annual Report Analysis (Annual Result Update)

Aug 5, 2020 | Updated on Aug 5, 2020

Here's an analysis of the annual report of INFOSYS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of INFOSYS. Also includes updates on the valuation of INFOSYS.

INFOSYS 2018-19 Annual Report Analysis (Annual Result Update)

May 21, 2019 | Updated on May 21, 2019

Here's an analysis of the annual report of INFOSYS for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of INFOSYS. Also includes updates on the valuation of INFOSYS.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE IT


Mar 2, 2021 (Close)

S&P BSE IT 5-YR ANALYSIS

COMPARE COMPANY

MARKET STATS